Up next
Author
Share article
The post has been shared by 0 people.
Facebook 0
Twitter 0
Pinterest 0
Mail 0

© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

(Reuters) – The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron (NASDAQ:) Pharmaceuticals’ eye disease drug Eylea, the company said in a statement on Friday.

Reuters

Source link

You May Also Like

EU raises bar for using sustainability-related terms in fund names | Insights | Bloomberg Professional Services

This article was written by Murat Bozdemir, ESG Data Solutions Product Manager,…

It Takes Two: Porting 2021’s game of the year to Switch

It Takes Two was one of the most successful games of 2021,…

Video gamers face a poorer reality as YouTube and Twitch reconsider multi-million dollar streaming deals: ‘I don’t think that’s a sustainable business’

Amazon.com’s Twitch and Alphabet’s YouTube are phasing out big-money content deals with…

Ukraine’s Zelenskiy to address Mexican lawmakers on Thursday By Reuters

© Reuters. FILE PHOTO: Ukrainian President Volodymyr Zelenskiy attends a joint news…